CytRx Corp.
(Other OTC/NBB : CYTR)

( )
CYTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -1.28%98.565.4%$171.46m
SAVACassava Sciences, Inc. -4.12%43.960.0%$168.58m
VRXValeant Pharmaceuticals International, Inc. 2.49%24.3214.1%$143.10m
CTLTCatalent, Inc. -1.29%120.892.0%$127.87m
ICLRICON plc -2.52%265.942.8%$108.47m
CPIXCumberland Pharmaceuticals, Inc. 51.20%6.940.6%$98.35m
JAZZJazz Pharmaceuticals Plc 1.04%121.512.1%$77.60m
UTHRUnited Therapeutics Corp. 1.47%188.7213.9%$72.58m
PRGOPerrigo Co. Plc 3.47%37.036.9%$66.48m
BHCBausch Health Cos., Inc. 2.49%24.320.0%$59.40m
ARGXargenx SE -1.67%278.960.0%$57.06m
ENDPEndo International Plc 0.60%5.028.5%$32.54m
CORTCorcept Therapeutics, Inc. 6.36%22.245.5%$26.01m
IRWDIronwood Pharmaceuticals, Inc. 1.91%11.199.5%$25.26m
PCRXPacira Biosciences, Inc. 2.99%54.109.8%$25.19m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.